Bellaire, TX, United States of America

Patricia Eifel



Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Patricia Eifel in Brachytherapy

Introduction

Patricia Eifel, a prominent inventor based in Bellaire, Texas, has made significant contributions to the field of medical technology, particularly in brachytherapy. With a total of two patents to her name, Eifel's work demonstrates her dedication to improving cancer treatment methodologies through innovative solutions.

Latest Patents

Eifel's latest patents focus on the development of an adaptive intracavitary brachytherapy applicator. This invention is a novel adaptive CT-friendly device featuring remotely-controlled radial and longitudinal motion radioactive source lumen shields. These shields can be manipulated by the radiation oncologist to optimize dose distribution to both the cancerous target and the surrounding normal tissue structures during brachytherapy procedures. This advancement promises to enhance the efficacy of cancer treatments while minimizing damage to healthy tissues.

Career Highlights

Patricia Eifel is affiliated with the University of Texas System, where her research and innovations continue to thrive. Her work embodies the commitment to excellence and innovation that is integral to the institution. Eifel’s inventions reflect her expertise and her passion for using technology to transform healthcare.

Collaborations

Throughout her career, Eifel has collaborated with esteemed colleagues, including Firas Mourtada and John Horton. These collaborations have furthered her work in brachytherapy and solidified her reputation as a leader in medical innovation.

Conclusion

Patricia Eifel’s contributions to brachytherapy exemplify the important intersection of technology and health care. Her patents not only demonstrate her innovative spirit but also her commitment to enhancing patient outcomes in cancer treatment. As she continues her work at the University of Texas System, the medical community eagerly anticipates the future advancements she will bring forth.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…